LLY News and Press, Eli Lilly and Company From 05/16/24

2024-05-16 06:48:39 ET More on Roche Roche: Value Remains Despite Covid-19 Revenue Growth Loss Roche Holding AG (RHHBY) Q1 2024 Sales/Trading Statement Call Transcript Q1 2024 Sales/ Trading Statement Call J&J, Roche, AstraZeneca poised to have highest or...

2024-05-15 16:27:14 ET Read the full article on Seeking Alpha For further details see: Duquesne Family Office top Q1 buys, cuts: Coherent, Eli Lilly, others

2024-05-15 11:17:39 ET Alphabet Class C ( GOOG ), Walmart ( WMT ) and Mastercard ( MA ) lead the list of least shorted S&P 500 stocks as a percentage of float in April.... Read the full article on Seeking Alpha For further details see: Least shorted S&P 5...

2024-05-15 10:21:25 ET Short percentage in S&P 500’s healthcare companies dipped at the end of April from March, as the life science tools and services sub-sector saw a huge drop in short interest from the previous month, while biotechnology emerged as the most shorted sector.......

2024-05-15 10:11:37 ET Summary Amphastar Pharmaceuticals, Inc. stock is down approximately 30% this year, and the company reported mixed Q1 results last week. Despite the poor performance of the stock so far in 2024, there are some positives on the company and its stock. An up...

2024-05-15 08:45:36 ET Summary Pfizer has been a losing investment for several years, but stronger trading momentum is starting to appear. An easily covered and safety-minded 6% dividend yield is very attractive today. Undervaluation arguments to own shares also exist. PFE sto...

Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer PR Newswire INDIANAPOLIS , May 15, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that Alonzo Weems, executive vi...

2024-05-15 05:44:00 ET Shares of Eli Lilly (NYSE: LLY) are up by a shocking 309% over the last three years, and, as smart investors know, a lot of that gain is attributable to just two words. Both of those words are the names of the company's rising-star medicines. And the proje...

2024-05-14 10:39:47 ET More on Eli Lilly Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety Eli Lilly: Don't Overpay For Miracle Drugs Lilly could partner with Cipla to market GLP-1 drugs ...

2024-05-14 09:53:00 ET It's a truism in the stock market that winners tend to keep winning. For pharmaceutical companies, making good on that axiom requires a lot of hard work to develop new medicines, and to find ways of adding to established markets that are addressable by their existing ...